McKesson Ventures
  • Portfolio
  • News
    • In the News
    • Press Releases
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Forbes’ 2024 List of America’s Best Startup Employers

by McKesson Ventures | Mar 5, 2024 | Portfolio News

McKesson Ventures portfolio companies Aledade Inc, Lightship, and Xealth were recently named among Forbes magazine’s list of America’s Best Startup Employers. Forbes partnered with third-party research firm Statista to assess over 3,000 companies, primarily examining...

Lightship® and Acclinate Announce Partnership to Increase Access to Clinical Trials for Diverse Populations

by McKesson Ventures | Sep 28, 2022 | Press Releases

Lightship is teaming up with digital health company Acclinate to increase access to and engagement of diverse participants in a decentralized neurology clinical trial for a large pharmaceutical company. Beyond the neurology trial, the partnership aims to increase...

Lightship Raises $40 Million to Bring Clinical Trials to Every Patient in Need

by McKesson Ventures | Oct 6, 2021 | Press Releases

Lightship, a virtual-first provider of clinical trials, today announced that it has raised $40 million to create access to clinical research for all patients, and improve diversity among patient groups taking part in clinical trials around the world. The funding round...

Lightship, Inc. Market Research Confirms Patients’ Interest in Direct-to-Patient Trial Offering Amidst COVID-19 Pandemic

by McKesson Ventures | May 29, 2020 | Press Releases

Lightship, a global direct-to-patient clinical trial company, recently announced the results of a nationwide market research survey designed to capture patients’ opinions surrounding clinical trial participation during the COVID-19 pandemic. The results indicated that...

Lightship Closes $20M Series B Financing Led by McKesson Ventures and Define Ventures and Appoints David MacMurchy as CEO

by McKesson Ventures | Feb 5, 2020 | Portfolio News

Lightship, a provider of enterprise level, direct-to-patient clinical research solutions, announced a $20 million investment led by McKesson Ventures and Define Ventures with participation from Khosala Ventures, Brook Byers, and Marc Benioff. “We launched Lightship...

Recent Posts

  • Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials
  • Lynx Closes $27 Million Oversubscribed Series A, Aims to Revolutionize Healthcare Payments and Administration
  • HarmonyCares Announces 2023 Results for its High Needs REACH ACO
  • Reimagine Care and Memorial Hermann Health System Unveil Expanded On-Demand Cancer Care Partnership
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

Contact Us

Cookie Settings

In the News

Lumata Health Secures $23 Million Series B to Expand Access and Adherence to Vision-Saving Care

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

Lynx Closes $27 Million Oversubscribed Series A, Aims to Revolutionize Healthcare Payments and Administration

HarmonyCares Announces 2023 Results for its High Needs REACH ACO

©2025 McKesson Ventures | Privacy Notice | Disclaimer
  • Follow
  • Follow